Luja™ female: designed to reduce the risk of UTI's1,2

What would reducing the risk of UTI's mean to you?

We understand how important it is for you as a catheter user to avoid urinary tract infections (UTIs). Any urine left in the bladder after catheterisation can contain bacteria that may multiply and could potentially cause a UTI2,3​.

​That’s why Luja female has unique Micro-hole Zone Technology that enables complete bladder emptying in one free flow4 for less risk of UTIs1.​

 

Urine left in the bladder after catheterisation is a perfect breeding ground for bacteria and this can cause UTIs3. Luja with its novel Micro-Hole Zone technology enables you to completely empty your bladder in one free flow4 – reducing your risk of getting a UTI2.  

With Luja female your emptying technique is made simpler4,5, as it enables you to empty your bladder without having to adjust the catheter4. In fact, 95% of users found it easy to use Luja female6.

So when the flow stops, you’re done4.

Conventional two-eyelet catheters can cause the bladder lining to be sucked into the eyelets during catheterisation causing discomfort and a stop-start flow of urine8. With Luja this suction is greatly reduced9 and during a recent study, users of Luja female said that they experienced no discomfort during catheterisation with Luja female7.

Luja female: purposefully designed with your needs and environment in mind

To reduce the environmental footprint of our new products, we take sustainability into account form the very beginning of the development process.

The container material is recyclable​.

Luja female has a 22% reduction in CO2 emissions compared to SpeediCath® Compact Eve14.

Request your sample of Luja female today

All sample requests are individually reviewed by our Clinical Services team and we will contact you to ensure the product is the right fit for you.

What time of day works best for our Clinical Solutions team to give you a call?


Your anatomy:

I have had my continence needs assessed by a Healthcare Professional and prescribed to use intermittent self catheters*

Would you like to stay informed?
From time to time, we, Coloplast Limited, would like to let you know about relevant Coloplast products and services; share inspirational stories from other customers; or tell you about forthcoming events via phone, text, email, or post. Our communication to you will be based on the information you provided to us and your preferences and interests, including your heath data. The choice is yours – and as with any of our services, you may opt-out at any time. Keep me informed by:




1. Luja female ensured zero flow stops in 87% of catheterisations & <10 mL residual urine at first flow stop in 83% of catheterisations (Thiruchelvam et al. (2024), DOI:10.12968/bjon.2024.0212 (20). Individual results may vary.

2. UTI risk factors defined by Kennelly, M., Thiruchelvam, N., Averbeck, M.A., Adult Neurogenic Lower Urinary Tract Dysfunction and Intermittent Catheterisation in a Community Setting: Risk Factors Model for Urinary Tract Infections, Adv Urol., 2019; 2:2019:2757862

3. Vasudeva, P. and Madersbacher, H., Factors implicated in pathogenesis of urinary tract infections in neurogenic bladders: some revered, few forgotten, others ignored, Neurourol Urodyn., 2014; 33(1):95-100

4. Luja female ensured zero flow stops in 87% of catheterisations & <10 mL residual urine at first flow stop in 83% of catheterisations (Thiruchelvam et al. (2024), DOI: 10.12968/bjon.2024.0212 (20). Individual results may vary.

5. Simpler procedure with one position compared to conventional eyelet catheters*

6. Coloplast Data-on-File, RCT, NCT05814211, 03/2024, n=82, 95% CI: [0.87; 0.99]

7. Coloplast Data-on-File, RCT, NCT05814211, n=82. 01/2024

8. Tentor F, Grønholt Schrøder B, Nielsen S, et al. Development of an ex-vivo porcine lower urinary tract model to evaluate the performance of urinary catheters. Sci Rep. 2022;12(1):17818.

9. **Tested in a pre-clinical setting (ex vivo). Coloplast Data-on-File, Glahn, 2023

10. Coloplast Data-on-File, RCT, NCT05814211, 03/2024, n=82, p<0.001

11. Stensballe J, Looms D, Nielsen PN, et al. Hydrophilic-coated catheters for intermittent catheterisation reduce urethral micro trauma: a prospective, randomised, participant- blinded, crossover study of three different types of catheters. Eur Urol 2005;48(6):978–83.

12. UTI risk factors defined by Kennelly, M., Thiruchelvam, N., Averbeck, M.A., Adult Neurogenic Lower Urinary Tract Dysfunction and Intermittent Catheterisation in a Community Setting: Risk Factors Model for Urinary Tract Infections, Adv Urol., 2019; 2:2019:2757862

14. Product design, use and local waste management specifics may limit recyclability.

15. Based on 22% CO2e emission reduction compared to SpeediCath Compact Eve, catheterising 4-6 times per day (EAUN guidelines, 2013). Based on externally reviewed carbon footprint according to ISO14067

 

Coloplast Ambassador has been compensated for their time.

Close

Sample request

Thank you

Your sample request has been received successfully

View desktop version